KRASG12C mutant lung adenocarcinoma unique biology, novel therapies and new challenges /
KRAS mutant lung cancer is the most prevalent molecular subclass of adenocarcinoma (LUAD), which is a heterogenous group depending on the mutation-type which affects not only the function of the oncogene but affects the biological behavior of the cancer as well. Furthermore, KRAS mutation affects ra...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2024
|
| Sorozat: | PATHOLOGY AND ONCOLOGY RESEARCH
29 |
| Tárgyszavak: | |
| doi: | 10.3389/pore.2023.1611580 |
| mtmt: | 34531676 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/29867 |